These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1375 related items for PubMed ID: 8542946

  • 1. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
    Slavin S, Naparstek E, Nagler A, Ackerstein A, Kapelushnik J, Or R.
    Exp Hematol; 1995 Dec; 23(14):1553-62. PubMed ID: 8542946
    [Abstract] [Full Text] [Related]

  • 2. Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies.
    Naparstek E, Nagler A, Or R, Kapelushnik J, Slavin S.
    Clin Transpl; 1996 Dec; ():281-90. PubMed ID: 9286578
    [Abstract] [Full Text] [Related]

  • 3. Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation.
    Slavin S, Naparstek E, Nagler A, Ackerstein A, Samuel S, Kapelushnik J, Brautbar C, Or R.
    Blood; 1996 Mar 15; 87(6):2195-204. PubMed ID: 8630379
    [Abstract] [Full Text] [Related]

  • 4. Alpha-interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease.
    Posthuma EF, Marijt EW, Barge RM, van Soest RA, Baas IO, Starrenburg CW, van Zelderen-Bhola SL, Fibbe WE, Smit WM, Willemze R, Falkenburg JH.
    Biol Blood Marrow Transplant; 2004 Mar 15; 10(3):204-12. PubMed ID: 14993886
    [Abstract] [Full Text] [Related]

  • 5. Allogeneic peripheral blood progenitor cells for treatment of relapse after bone marrow transplantation.
    Glass B, Majolino I, Dreger P, Scimè R, Santoro A, Vasta S, Suttorp M, Haferlach T, Schmitz N.
    Bone Marrow Transplant; 1997 Oct 15; 20(7):533-41. PubMed ID: 9337054
    [Abstract] [Full Text] [Related]

  • 6. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL.
    Dan Med Bull; 2007 May 15; 54(2):112-39. PubMed ID: 17521527
    [Abstract] [Full Text] [Related]

  • 7. Donor leukocyte infusions for recurrent hematologic malignancies after allogeneic bone marrow transplantation: impact of infused and residual donor T cells.
    Verdonck LF, Petersen EJ, Lokhorst HM, Nieuwenhuis HK, Dekker AW, Tilanus MG, de Weger RA.
    Bone Marrow Transplant; 1998 Dec 15; 22(11):1057-63. PubMed ID: 9877267
    [Abstract] [Full Text] [Related]

  • 8. Adoptive immunotherapy with donor mononuclear cell infusions to treat relapse of acute leukemia or myelodysplasia after allogeneic bone marrow transplantation.
    Porter DL, Roth MS, Lee SJ, McGarigle C, Ferrara JL, Antin JH.
    Bone Marrow Transplant; 1996 Nov 15; 18(5):975-80. PubMed ID: 8932854
    [Abstract] [Full Text] [Related]

  • 9. Allogeneic or autologous bone marrow transplantation for acute lymphoblastic leukemia in first complete remission.
    Blaise D, Gaspard MH, Stoppa AM, Michel G, Gastaut JA, Lepeu G, Tubiana N, Blanc AP, Rossi JF, Novakovitch G.
    Bone Marrow Transplant; 1990 Jan 15; 5(1):7-12. PubMed ID: 2404531
    [Abstract] [Full Text] [Related]

  • 10. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
    Ortega JJ, Díaz de Heredia C, Olivé T, Bastida P, Llort A, Armadans L, Torrabadella M, Massuet L.
    Haematologica; 2003 Mar 15; 88(3):290-9. PubMed ID: 12651268
    [Abstract] [Full Text] [Related]

  • 11. Allogeneic bone marrow transplantation for leukemia with marrow grafts treated by counterflow centrifugation.
    De Witte T, Schattenberg A, Preijers F, Raymakers R, Muus P, Wessels J.
    Bone Marrow Transplant; 1993 Mar 15; 12 Suppl 3():S2-6. PubMed ID: 8124252
    [Abstract] [Full Text] [Related]

  • 12. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation.
    Lemoli RM, Bandini G, Leopardi G, Rosti G, Bonini A, Fortuna A, Rondelli D, Mangianti S, Motta MR, Rizzi S, Tassi C, Cavo M, Remiddi C, Curti A, Conte R, Tura S.
    Haematologica; 1998 Jan 15; 83(1):48-55. PubMed ID: 9542323
    [Abstract] [Full Text] [Related]

  • 13. Effect of induced GVHD in leukemia patients relapsing after allogeneic bone marrow transplantation: single-center experience of 33 adult patients.
    Min CK, Eom KS, Lee S, Kim DW, Lee JW, Min WS, Kim CC.
    Bone Marrow Transplant; 2001 May 15; 27(9):999-1005. PubMed ID: 11436112
    [Abstract] [Full Text] [Related]

  • 14. Successful second allogeneic peripheral blood stem cell transplantation and donor lymphocyte infusion in patients with relapsed acute leukemia using the same donors as for the initial allogeneic bone marrow transplantation.
    Ishikawa J, Maeda T, Kashiwagi H, Yoshida H, Takahashi I, Kawamoto SI, Yamada M, Kato H, Nishiura T, Tomiyama Y, Matsuzawa Y.
    Bone Marrow Transplant; 2003 Jun 15; 31(11):1057-9. PubMed ID: 12774060
    [Abstract] [Full Text] [Related]

  • 15. [The success of lymphocyte infusion as treatment of leukemia recurrence following allogeneic bone marrow transplantation depends on low percentage of patient's own lymphocytes].
    Schattenberg AV, van de Wiel-van Kemenade E, Bär BM, Geurts van Kessel AH, van der Maazen RW, de Witte TJ.
    Ned Tijdschr Geneeskd; 1996 Oct 19; 140(42):2087-91. PubMed ID: 8965951
    [Abstract] [Full Text] [Related]

  • 16. Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies.
    Uderzo C, Dini G, Locatelli F, Miniero R, Tamaro P.
    Haematologica; 2000 Nov 19; 85(11 Suppl):47-53. PubMed ID: 11268324
    [Abstract] [Full Text] [Related]

  • 17. High-dose melphalan and allogeneic peripheral blood stem cell transplantation for treatment of early relapse after allogeneic transplant.
    de Lima M, van Besien K, Gajewski J, Khouri I, Andersson B, Korbling M, Champlin R, Giralt S.
    Bone Marrow Transplant; 2000 Aug 19; 26(3):333-8. PubMed ID: 10967575
    [Abstract] [Full Text] [Related]

  • 18. Persistent donor chimaerism is consistent with disease-free survival following BMT for chronic myeloid leukaemia.
    Gardiner N, Lawler M, O'Riordan J, DeArce M, Humphries P, McCann SR.
    Bone Marrow Transplant; 1997 Aug 19; 20(3):235-41. PubMed ID: 9257892
    [Abstract] [Full Text] [Related]

  • 19. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
    Gordon BG, Warkentin PI, Strandjord SE, Abromowitch M, Bayever E, Harper JL, Coccia PF.
    Bone Marrow Transplant; 1997 Jul 19; 20(1):5-10. PubMed ID: 9232249
    [Abstract] [Full Text] [Related]

  • 20. [Indications, technique and risks in bone marrow transplantation in adulthood].
    Heyll A, Söhngen D, Minning H, Meckenstock G, Aul C, Schneider W.
    Praxis (Bern 1994); 1996 Mar 19; 85(12):378-86. PubMed ID: 8643901
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 69.